Cerity Partners’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
BBA
Cerity Partners's FTH Position: Q3 2026 in Review
Cerity Partners opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 9,378 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2867 among its holdings.
79 funds tracked by Wall St. Rank hold FTH as of Q3 2026.
- Cerity Partners held 9,378 shares of Faeth Therapeutics worth $279K as of Q3 2026.
- Faeth Therapeutics was a new Cerity Partners position in Q3 2026.
- Faeth Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2867 holding.
- 79 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.
Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.